Moria, Nygell G.
HRN: 25-33-59 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2024
CEFUROXIME 750MG (VIAL)
06/23/2024
06/30/2024
IV
500mg
Q8H
Stab Wound, Adbomen
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes